XML 37 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

Investment In Inex Bio, Inc (Tables)

9 Months Ended

Sep. 30, 2015

Summary of Purchase Price Paid to Inex Bio

The following summarizes the net consideration paid to Holdings:

Consideration		Total
Cash		$	6,518
Fair value of warrants			22,747
Less cash paid to acquire shares in Inex Bio			(1,100	)
Net consideration		$	28,165

Summary of Assets and Liabilities Assumed

The following table summarizes the assets acquired and liabilities assumed:

Cash		$	763
Intangible assets—reacquired rights of Company technology			7,199
Other assets			12
Investment in Inex Bio			(221	)
Accounts payable			(1	)
Total assets acquired and liabilities assumed		$	7,752

Inex Bio Inc

Summary of Purchase Price Paid to Inex Bio

The purchase price paid to acquire Inex Bio from the other owners is as follows:

Consideration		Total
Cash paid by InexBio Holdings, LLC		$	1,100
Cash paid by Company			1,482
Fair value of warrants			5,170
Aggregate purchase price		$	7,752

X

- Definition

Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 805



-SubTopic 20



-Section 50



-Paragraph 1



-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=nk_InexBioIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: